• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Oct31
Fudan Zhangjiang Changes A-Share Raised Funds Purpose to Support Photodynamic Drug R&D
15:31
Oct30
Fudan-Zhangjiang released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 160.99 M, actual EPS CNY -0.0828
01:00
Fudan-Zhangjiang released FY2025 9 Months Earnings on October 30 After-Market (BJT), Actual Revenue: CNY 551.08 M, Actual EPS: CNY -0.0773
01:00
Oct22
Fudan-Zhangjiang to Release FY2025 Q3 Earnings on October 30 After-Market BJT
02:35
Oct13
Affiliate of Fudan Zijang's Obeticholic Acid Tablets Application for Market Approval Rejected
10:04
Aug12
Fudan Zhangjiang Reports 91.89% Drop in Net Profit in H1 2025
10:52

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 160.99 M, Net Income -21.65 M, EPS -0.0828

Aug12
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 210.18 M, Net Income 3.05 M, EPS 0.0029

Apr28
Earning Release(CST)

FY2025 Q1 Earning Release (CNY) Revenue 179.91 M, Net Income 2.665 M, EPS 0.0025

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy